Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

FDA Grants Exousia Pro Orphan Drug Designation in Glioma

October 29th 2025, 4:00pm

Article

Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

October 27th 2025, 3:00pm

Article

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

FDA Fast Tracks MT-125 for Glioblastoma

October 24th 2025, 1:29pm

Article

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.

GammaTile May Reduce Risk of Brain Tumor Recurrence or Death

October 21st 2025, 3:00pm

Article

In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

Registration Open for the National Caregivers Self-Care and Tools Webinar Hosted by the End Brain Cancer Initiative

October 16th 2025, 9:58pm

Article

Registration is now open for the National Caregivers Self-Care and Tools online educational event on November 7th, 2025 at 11AM Pacific Time.

FDA Grants Orphan Drug Status to Cintredekin Besudotox for Glioblastoma

October 7th 2025, 3:00pm

Article

The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this aggressive brain cancer.

What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?

October 6th 2025, 1:00pm

Video

CAR-T cell therapy has cured some children with blood cancers and is being studied in solid tumors, where responses differ due to how these cancers grow.

How FDA-Approved Modeyso Works to Treat Glioma

September 28th 2025, 6:00pm

Video

Dr. Patrick Wen discussed with CURE how Modeyso treats diffuse midline glioma, and what unmet needs remain for patients now that the therapy is available.

FDA Grants Orphan Drug Designation to BA-101 in Glioblastoma

September 8th 2025, 3:02pm

Article

The FDA has granted orphan drug designation to the investigational therapy BA-101 for the treatment of patients with glioblastoma.

Every Oncologic FDA Approval Throughout August 2025

September 2nd 2025, 7:00pm

Article

In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung cancer and brain cancer.